Srs Capital Advisors, Inc. Glaukos Corp Transaction History
Srs Capital Advisors, Inc.
- $1.95 Billion
- Q2 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 115 shares of GKOS stock, worth $10,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
115
Previous 8
1337.5%
Holding current value
$10,052
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GKOS
# of Institutions
334Shares Held
54MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$703 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$534 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$284 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$183 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$175 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.16B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...